Search
Search
To the Point
10.08.24
Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receptor potential receptors, and more.
View full description +
Subscribe
10.24.25
Aesthetics and the Ocular SurfaceJackie Garlich, OD; FAAO, Jessilin Quint, OD, MS, MBA, FAAO; and Tracy Doll, OD, FAAO,
09.10.25
Running a Standalone Dry Eye ClinicJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; Jason Besecker, OD, MS
08.13.25
Building Out a Dry Eye and Aesthetics PracticeJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Shane Swatts, OD
07.08.25
Takeways From the TFOS DEWS III ReportJackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO; and Vin T. Dang, OD, FAAO
06.11.25
A Lesson in Blink Mechanics and Dry EyeJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Cory J. Lappin, OD, MS, FAAO
05.12.25
Is it Dry Eye or Corneal Pathology?Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Bita Asghari, OD, FAAO, FSLS
04.09.25
Take Ownership of Your Career in Dry EyeJackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO
03.11.25
Learn How Vitamin A Supports the Ocular SurfaceJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Kaleb Abbott, OD, FAAO
Show More
